This second public webinar is for technical experts from industry and national competent authorities wishing to learn more about the design of the FHIR message for the first form to be updated: Human Variations.
Despite the focus on human medicines, all stakeholders interested in the technical aspects of the FHIR message are welcome.
Topics addressed in this webinar include the: